Company / Cash per Share
SUTRO BIOPHARMA, INC. Cash per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$7.00
FY2025
5-year range
$0.66 / $7.00
FY2021-FY2025
Trend
+124.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has increased for 3 consecutive years, from $0.66 in FY2022 to $7.00 in FY2025.
Based on SEC 10-K filings.
7.00 in FY2025 with a 5-year CAGR of +100.7%.
Improved from $0.82 to $7.00 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +120.1%
- 5-Year CAGR
- +100.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- SUTRO BIOPHARMA, INC.'s cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 124.4% year-over-year.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -3.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.00 | +124.4% |
| FY2024 | $3.12 | +279.6% |
| FY2023 | $0.82 | +25.2% |
| FY2022 | $0.66 | -85.4% |
| FY2021 | $4.51 | +1998.4% |
| FY2020 | $0.21 | -96.1% |
| FY2019 | $5.48 | -88.4% |
| FY2018 | $47.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026